Vor Biopharma (VOR) Operating Leases (2020 - 2026)
Vor Biopharma (VOR) posted quarterly Operating Leases of $2.6 million for Q1 2026, down 90.07% year-over-year from $26.5 million in Q1 2025, and down 3.24% quarter-over-quarter from $2.7 million in Q4 2025.
Vor Biopharma (VOR) Operating Leases (2020 - 2026) Analysis & Trends
Vor Biopharma (VOR) has reported Operating Leases for 7 consecutive years, with $2.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Leases fell 90.07% year-over-year to $2.6 million; the TTM figure through Mar 2026 stood at $2.6 million (down 90.07% YoY), while the FY2025 annual figure was $2.7 million, down 90.15% from the prior year.
- Operating Leases eased to $2.6 million in Q1 2026 per VOR's latest filing, from $2.7 million in the prior quarter.
- Across five years, Operating Leases topped out at $37.4 million in Q2 2022 and bottomed at $2.6 million in Q1 2026.
- Historically, Operating Leases has averaged $26.0 million across 5 years, with a median of $30.2 million in 2024.
- Annual changes were most pronounced in 2022 — Operating Leases surged 123.41% — and 2025, when it tumbled 90.22%.
- Vor Biopharma's Operating Leases stood at $35.6 million in 2022, then decreased by 10.69% to $31.8 million in 2023, then retreated by 13.24% to $27.6 million in 2024, then sank by 90.15% to $2.7 million in 2025, then fell by 3.24% to $2.6 million in 2026.
- Business Quant data shows VOR's Operating Leases at $2.6 million in Q1 2026, $2.7 million in Q4 2025, and $2.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Vor Biopharma | 1.36 Bn | 1.36 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.54 Mn |
| Mar 31, 2026 | 2.63 Mn |
| Dec 31, 2025 | 2.72 Mn |
| Sep 30, 2025 | 2.81 Mn |
| Mar 31, 2025 | 26.52 Mn |
| Dec 31, 2024 | 27.62 Mn |
| Sep 30, 2024 | 28.69 Mn |
| Jun 30, 2024 | 29.71 Mn |
| Mar 31, 2024 | 30.78 Mn |
| Dec 31, 2023 | 31.83 Mn |
| Sep 30, 2023 | 32.85 Mn |
| Jun 30, 2023 | 33.82 Mn |
| Mar 31, 2023 | 34.74 Mn |
| Dec 31, 2022 | 35.64 Mn |
| Sep 30, 2022 | 36.54 Mn |
| Jun 30, 2022 | 37.38 Mn |
| Mar 31, 2022 | 21.68 Mn |
| Dec 31, 2021 | 16.17 Mn |
| Sep 30, 2021 | 16.47 Mn |
| Jun 30, 2021 | 16.73 Mn |